Prevalence and correlates of unmet supportive care needs in patients with resected invasive cutaneous melanoma.

BACKGROUND Knowledge about supportive care needs in patients with cutaneous invasive melanoma is scarce. We examined the unmet needs of melanoma patients treated with surgery and factors associated with these needs to assist health professionals identify areas needing clinical attention. PATIENTS AND METHODS Cross-sectional multisite survey of UK patients ascertained 3 months to 5 years after complete resection of stage I-III cutaneous melanoma. Participants completed the following validated questionnaires: Supportive Care Needs Survey (SCNS-SF34 with melanoma module), Hospital Anxiety and Depression Scale and 51-item Functional Assessment of Cancer Therapy-Melanoma quality-of-life scale. RESULTS A total of 472 participants were recruited [319 (67%) clinical stage I-II). Mean age was 60 years (standard deviation = 14) and 255 (54%) were female. One hundred and twenty-three (27%) participants reported at least one unmet need (mostly 'low' level). The most frequently reported unmet needs were fears of cancer returning (n = 138, 29%), uncertainty about the future (n = 119, 25%), lack of information about risk of recurrence (n = 112, 24%) and about possible outcomes if melanoma were to spread (n = 91, 20%). One hundred and thirty-eight (29%) participants reported anxiety and 51 (11%) depression at clinical or subclinical levels. Patients with nodal disease had a significantly higher level of unmet supportive care needs (P < 0.001) as did patients with anxiety or depression (P < 0.001). Key correlates of the total SCNS-SF34 score for unmet supportive care needs were younger age (odds ratio, OR = 2.23, P < 0.001) and leaving school early (OR = 4.85, P < 0.001), while better emotional (OR = 0.89, P < 0.001) and social well-being (OR = 0.91, P < 0.001) were linked with fewer unmet needs. Neither patients' sex nor tumour thickness was associated with unmet needs. CONCLUSIONS Around a quarter of melanoma patients may have unmet support needs in the mid to long term after primary treatment. In particular, patients who are younger, less educated, distressed or socially isolated could benefit from more support.

[1]  P. Schofield Supportive care needs in patients with lung cancer , 2014 .

[2]  C. D’Este,et al.  Prevalence and correlates of cancer survivors’ supportive care needs 6 months after diagnosis: a population-based cross-sectional study , 2012, BMC Cancer.

[3]  P. Butow,et al.  Evidence-based Dermatology: Study Psychological Responses and Coping Strategies among Patients with Malignant Melanoma a Systematic Review of the Literature for Editorial Comment See Page 1439 , 2022 .

[4]  J. Coebergh,et al.  A systematic review of health-related quality of life in cutaneous melanoma , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  M. Stockler,et al.  The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross‐sectional study , 2013, Psycho-Oncology.

[6]  A. Molassiotis,et al.  A systematic review of complementary and Alternative medicine interventions in the management of cancer-related fatigue , 2011, BMJ Supportive & Palliative Care.

[7]  R. Snaith,et al.  The hospital anxiety and depression scale. , 2013, Acta psychiatrica Scandinavica.

[8]  R. Sanson-Fisher,et al.  The unmet supportive care needs of patients with cancer , 2000, Cancer.

[9]  D. Cella,et al.  The Queensland cancer risk study: general population norms for the Functional Assessment of Cancer Therapy–General (FACT‐G) , 2008, Psycho-oncology.

[10]  M. Ross,et al.  Prospective assessment of the reliability, validity, and sensitivity to change of the functional assessment of cancer Therapy‐Melanoma questionnaire , 2008, Cancer.

[11]  Jennifer L. Schwartz,et al.  Cognitive‐behavioral intervention for distress in patients with melanoma , 2003, Cancer.

[12]  G. L. Engel,et al.  The clinical application of the biopsychosocial model. , 1980, The American journal of psychiatry.

[13]  Trevor Murrells,et al.  Patients' supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  A. Gafni,et al.  The supportive care needs of newly diagnosed cancer patients attending a regional cancer center , 1997, Cancer.

[15]  A. Molassiotis,et al.  Unmet supportive care needs, psychological well‐being and quality of life in patients living with multiple myeloma and their partners , 2011, Psycho-oncology.

[16]  J. Cashy,et al.  General Population and Cancer Patient Norms for the Functional Assessment of Cancer Therapy-General (FACT-G) , 2005, Evaluation & the health professions.

[17]  A. Mitchell,et al.  Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. , 2013, The Lancet. Oncology.

[18]  A. Girgis,et al.  Brief assessment of adult cancer patients' perceived needs: development and validation of the 34-item Supportive Care Needs Survey (SCNS-SF34). , 2009, Journal of evaluation in clinical practice.

[19]  P. Butow,et al.  Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma , 2000, British Journal of Cancer.

[20]  J. Tomasone,et al.  Supportive care needs of Canadian melanoma patients and survivors. , 2012, Canadian oncology nursing journal = Revue canadienne de nursing oncologique.

[21]  J. Aitken,et al.  Does quality of life among breast cancer survivors one year after diagnosis differ depending on urban and non-urban residence? A comparative study , 2010, Health and quality of life outcomes.

[22]  D. Bloch,et al.  A simple method of sample size calculation for linear and logistic regression. , 1998, Statistics in medicine.

[23]  R. Sanson-Fisher,et al.  Assessing the Perceived Needs of Patients Attending an Outpatient Melanoma Clinic , 2000 .

[24]  T. Einarson,et al.  Advanced cutaneous malignant melanoma: a systematic review of economic and quality-of-life studies. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[25]  P. Butow,et al.  Breast cancer survivors’ supportive care needs 2–10 years after diagnosis , 2007, Supportive Care in Cancer.

[26]  G. L. Engel The clinical application of the biopsychosocial model. , 1980, The Journal of medicine and philosophy.

[27]  A. Molassiotis,et al.  A Systematic Review of Complementary and Alternative Medicine Interventions for the Management of Cancer-Related Fatigue , 2013, Integrative cancer therapies.

[28]  M. Ojanen,et al.  Baseline psychosocial predictors of survival in localized melanoma. , 2007, Journal of psychosomatic research.

[29]  J. Hainsworth,et al.  Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial. , 2013, The Lancet. Oncology.

[30]  W. Stolz,et al.  Quality of life in localised malignant melanoma. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  L. Emery,et al.  Mapping the psychosocial and practical support needs of cancer patients in Western Australia. , 2012, European journal of cancer care.

[32]  Jeffrey E Gershenwald,et al.  Final version of 2009 AJCC melanoma staging and classification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.